2e 2 5d 16
19
1b
38

Karen S Gustafson, MD, PhD

78 faculty photo 66
Associate Professor of Clinical Pathology and Laboratory Medicine
28
6d
Attending - HUP, Hospital of the University of Pennsylvania 1a Pathology & Lab Medicine 19 Anatomic Pathology
59
Consulting - PAH, Pennsylvania Hospital 1a Pathology & Lab Medicine 19 Anatomic Pathology
65
Consulting - PPMC, Penn Presbyterian Medical Center 1a Pathology & Lab Medicine 19 Anatomic Pathology
11
3 78
Department: Pathology and Laboratory Medicine
4 1 b
1d
46 Contact information
 57
University of Pennsylvania Medical Center
20 6 Founders, Room FO6.042
35 3400 Spruce Street
Philadelphia, PA 19104
26
2e Office: 215-662-3209
30
ad
Email: Karen.Gustafson@pennmedicine.upenn.edu
12
4 3 3 3 2 4 b 1f
13 Education:
21 9 B.A. 22 (Biology and Chemistry) c
32 Gustavus Adolphus College, 1983.
 21 c MD, PhD 1f (Biomedical Science) c
53 University of Minnesota Medical Scientist Training Program, 1998.
 c
3 3 3 3 8d Permanent link
2 29
 
1d
25
21
b6 > Perelman School of Medicine   > Faculty   > Details a
1e 1d
2b 29
23

Selected Publications

d4 Almasri B, Gustafson KS, Husson MA, Shanti RM, France K: Asymptomatic bilateral facial swelling. J Am Dent Assoc 154(3): 260-265, Mar 2023.

 bd Yu GH, Glaser LJ, Gustafson KS: Role of Ancillary Techniques in Fluid Cytology. Acta Cytologica 64: 52-62, Jan 2020.

 1a2 Vijayvergia, N., Boland, P. M., Handorf, E., Gustafson, K. S., Gong, Y., Cooper, H. S., Sheriff, F., Astsaturov, I. A., Cohen, S. J., Engstrom, P. F. : Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: A Fox Chase Cancer Center pilot study. British Journal of Cancer 115(5): 564-570, August 2016.

 18f Kaczmar, J.M., Gustafson, K.S., Wong, Y.N., Minniti, C.J., Sandilya, V.K., Sprandio, J.D., Chertock, Y., Hart, C., Hall, M.J.: Tumor genomic profiling (TGP) in metastatic colorectal cancer (CRC): Bridging the community and the tertiary cancer center through genomic consultation (GC). Journal of Clinical Oncology 34(4), 2016.

 183 Zih, F.S., Kulkarni, N., Escalante, D.A., Meade, C., Osevala, N., Zibelman, M., Movva, S., Gustafson, K.S., Wu, H., Reddy, S., Lango, M., Olszanski, A.J., Farma, J.: Molecular profiling and clinical outcomes in malignant melanoma: Experience at a NCI-designated cancer center. Annals of Surgical Oncology 23, 2016.

 174 Farma, J., Kulkarni, N., Escalante, D.A., Meade, C., Osevala, N., Zibelman, M., Gustafson, K.S., Wu, H., Lango, M., Reddy, S., Movva, S., Olszanski, A.J., Zih, F.S.: Molecular profiling and clinical outcomes in patients with in-transit recurrence of melanoma. Annals of Surgical Oncology 23, 2016.

 161 Vijayvergia, N., Cohen, S.J., Boland, P.M., Gustafson, K.S., Sherrif, F., Cooper, H., Astaturov, I., Engstrom, P.F.: Molecular profiling defines subsets of neuroendocrine tumors (NETs) with aggressive disease: A Fox Chase Cancer Center (FCCC) study. Pancreas 45(3): 469-470, 2016.

 158 Shih J, Bashir B, Gustafson KS, Andrake MA, Dunbrack RL, Goldstein LJ, Boumber Y. : CSI: Cancer Signature Investigation: ERBB2 (HER2)-activating mutation and amplification-positive breast carcinoma mimicking lung primary. J Natl Compr Canc Netw 13(8): 947-52, Aug 2015.

 14a Vijayvergia, N., Boland, P. M., Cohen, S. J., Gustafson, K. S., Cooper, H. S., Astsaturov, I. A., Engstrom, P. F. : Molecular profiling of neuroendocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. Journal of Clinical Oncology 33(3), 2015.

 153 Vijayvergia, N., Boland, P. M., Gustafson, K. S., Sheriff, F., Cooper, H. S., Cohen, S. J., Astsaturov, I. A., Engstrom, P. F.: Molecular profiling of advanced stage neuro endocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. Pancreas 44(2), 2015.

 2c
7 1d
2c back to top
26 Last updated: 07/28/2025
34 The Trustees of the University of Pennsylvania c
1f
27
24
 
1d
18
1 49 2 2 18